TGFbeta1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis.
Lundberg
Marie
M
Department of Otorhinolaryngology, Head and Neck Surgery, Helsinki University Central Hospital, PO Box 220, FI-00029 HUCH, Helsinki, Finland. marie.lundberg@helsinki.fi
Saarilahti
Kauko
K
Mäkitie
Antti A
AA
Mattila
Petri S
PS
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000532:radiotherapy; D003131:Combined Modality Therapy / Q000009:adverse effects; D018572:Disease-Free Survival; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D052016:Mucositis / Q000209:etiology / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011879:Radiotherapy Dosage; D015996:Survival Rate; D053773:Transforming Growth Factor beta1 / Q000235:genetics*
D053773:Transforming Growth Factor beta1